Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 06, 2020

SELL
$43.24 - $55.02 $134,044 - $170,562
-3,100 Closed
0 $0
Q4 2019

Feb 03, 2020

BUY
$54.32 - $64.31 $3,802 - $4,501
70 Added 2.31%
3,100 $186,000
Q3 2019

Oct 29, 2019

SELL
$53.25 - $59.98 $7,987 - $8,997
-150 Reduced 4.72%
3,030 $171,000
Q4 2018

Feb 14, 2019

BUY
$36.72 - $67.73 $30,477 - $56,215
830 Added 35.32%
3,180 $128,000
Q2 2018

Jul 19, 2018

SELL
$51.25 - $76.62 $138,887 - $207,640
-2,710 Reduced 53.56%
2,350 $178,000
Q4 2017

Feb 15, 2018

BUY
$49.6 - $60.87 $91,760 - $112,609
1,850 Added 57.63%
5,060 $270,000
Q3 2017

Nov 06, 2017

BUY
$46.62 - $60.36 $149,650 - $193,755
3,210
3,210 $191,000

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Municipal Employees' Retirement System Of Michigan Portfolio

Follow Municipal Employees' Retirement System Of Michigan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Municipal Employees' Retirement System Of Michigan, based on Form 13F filings with the SEC.

News

Stay updated on Municipal Employees' Retirement System Of Michigan with notifications on news.